Advisory Alpha, LLC Gilead Sciences, Inc. Transaction History

Advisory Alpha, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $24,982 - $28,466	-441 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $27,386 - $34,433	441 New	441 $28,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $37,255 - $43,260	-515 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $10,772 - $13,797	172 Added 50.15%	515 $40.1 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $5,915 - $6,506	96 Added 38.87%	343 $22.1 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $15,439 - $17,043	247 New	247 $15,000
Q2 2019 Aug 16, 2019	SELL	$61.87 - $69.38 $54,631 - $61,262	-883 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $55,213 - $61,854	883 New	883 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.